Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:DMT NASDAQ:FTRP CVE:KDA NASDAQ:TLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMTSmall PharmaC$0.15-6.3%C$0.15C$0.06▼C$0.22C$50.37M0.86296,159 shs1.89 million shsFTRPField Trip Health$1.12$2.76$0.71▼$6.41$65.20MN/A214,681 shsN/AKDAKDA GroupC$0.26-1.9%C$0.29C$0.20▼C$0.42C$48.02M0.74560895,544 shs30,058 shsTLTiShares 20+ Year Treasury Bond ETF$89.74+0.6%$86.81$83.29▼$101.64$50.17B0.0638.90 million shs40.63 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMTSmall Pharma0.00%0.00%0.00%0.00%0.00%FTRPField Trip Health0.00%0.00%0.00%0.00%0.00%KDAKDA Group+3.92%-1.85%-3.64%+6.00%+10.42%TLTiShares 20+ Year Treasury Bond ETF-0.57%+4.20%+2.22%+3.59%-10.76%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMTSmall PharmaC$0.15-6.3%C$0.15C$0.06▼C$0.22C$50.37M0.86296,159 shs1.89 million shsFTRPField Trip Health$1.12$2.76$0.71▼$6.41$65.20MN/A214,681 shsN/AKDAKDA GroupC$0.26-1.9%C$0.29C$0.20▼C$0.42C$48.02M0.74560895,544 shs30,058 shsTLTiShares 20+ Year Treasury Bond ETF$89.74+0.6%$86.81$83.29▼$101.64$50.17B0.0638.90 million shs40.63 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMTSmall Pharma0.00%0.00%0.00%0.00%0.00%FTRPField Trip Health0.00%0.00%0.00%0.00%0.00%KDAKDA Group+3.92%-1.85%-3.64%+6.00%+10.42%TLTiShares 20+ Year Treasury Bond ETF-0.57%+4.20%+2.22%+3.59%-10.76%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDMTSmall Pharma 0.00N/AN/AN/AFTRPField Trip Health 0.00N/AN/AN/AKDAKDA Group 0.00N/AN/AN/ATLTiShares 20+ Year Treasury Bond ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDMTSmall Pharma-C$1.16K-43,343.80C$0.13 per share1.13C$0.03 per share5.00FTRPField Trip Health$3.88M16.80N/AN/A$0.92 per share1.22KDAKDA GroupC$210.28K228.37C$0.05 per share5.00C$0.08 per share3.25TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDMTSmall Pharma-C$19.31M-C$0.07N/A∞N/AN/A-116.90%-66.00%N/AFTRPField Trip Health-$43.63M-$0.77N/AN/AN/A-1,125.12%-62.71%-47.29%N/AKDAKDA Group-C$1.73M-C$0.05N/A∞N/A5,414.15%-15.93%-11.56%N/ATLTiShares 20+ Year Treasury Bond ETFN/AN/AN/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDMTSmall PharmaN/AN/AN/AN/AN/AFTRPField Trip HealthN/AN/AN/AN/AN/AKDAKDA GroupN/A6.19%N/AN/AN/ATLTiShares 20+ Year Treasury Bond ETF$3.864.30%N/AN/AN/ALatest FTRP, DMT, TLT, and KDA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/29/2025TLTiShares 20+ Year Treasury Bond ETFmonthly$0.32814.6%9/2/20259/2/20259/5/20257/31/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.33084.52%8/1/20258/1/20258/6/20256/30/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.32834.47%7/1/20257/1/20257/7/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDMTSmall Pharma5.952.636.28FTRPField Trip Health0.408.208.20KDAKDA Group7.362.100.35TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDMTSmall Pharma0.67%FTRPField Trip Health16.84%KDAKDA GroupN/ATLTiShares 20+ Year Treasury Bond ETF73.33%Insider OwnershipCompanyInsider OwnershipDMTSmall Pharma31.08%FTRPField Trip HealthN/AKDAKDA Group25.51%TLTiShares 20+ Year Treasury Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDMTSmall Pharma13335.77 millionN/ANot OptionableFTRPField Trip Health10458.22 millionN/ANot OptionableKDAKDA Group3,100184.70 millionN/ANot OptionableTLTiShares 20+ Year Treasury Bond ETFN/A559.10 millionN/AOptionableFTRP, DMT, TLT, and KDA HeadlinesRecent News About These CompaniesTLT: Remember Last SeptemberSeptember 9 at 5:01 PM | seekingalpha.comTLT ETF Analysis As Outflows Slow Amid A Trump Tariff Silver Lining September 4, 2025 | talkmarkets.comA 12.2% Monthly Dividend from the World’s Safest Asset...September 2, 2025 | marketbeat.comInflation Fears Fuel The Bear SteepenerAugust 26, 2025 | seekingalpha.comCredit Spreads At Historical Lows, TLT Vs. VCLTAugust 24, 2025 | seekingalpha.comThis 12.2% Dividend Turns Safe Treasuries Into Monthly IncomeAugust 20, 2025 | investing.com3 Reasons the Market Can Rally, 2 Ways to Diversify If It Doesn't (TLT)...August 5, 2025 | marketbeat.comiShares 10-20 Year Treasury Bond ETF declares monthly distribution of $0.377287August 5, 2025 | msn.comVOO Slips, TLT Rises as July Jobs Report DisappointsAugust 2, 2025 | finance.yahoo.comBonds: Fiscal Discipline In DeclineAugust 1, 2025 | seekingalpha.comWhy Powell Is Right To Pause Despite Trump's ExasperationAugust 1, 2025 | seekingalpha.comTreasury To Flood The Market With T-BillsJuly 31, 2025 | seekingalpha.comHow Stablecoins Can Help The US Treasury Fund The Government's Fiscal DeficitJuly 24, 2025 | seekingalpha.comSharkey Howes Loads Up on 50,817 TLT SharesJuly 23, 2025 | fool.comTLT: Rate Expectations Down And Yields Up? It's All About The Term PremiumJuly 22, 2025 | seekingalpha.comTLT Slides as Fixed-Income Investors Brace for CPI ReportJuly 16, 2025 | finance.yahoo.comGovernor Waller Gets Candid About Fed's Balance Sheet Mismatch And LossesJuly 14, 2025 | seekingalpha.comTLT: The Upside Could Be Much Bigger Than You ThinkJuly 14, 2025 | seekingalpha.comA Massive Bear Steepener May Be About To Shock MarketsJuly 13, 2025 | seekingalpha.comDebt Ceiling Increase Will Allow U.S. Treasury To Resume BorrowingJuly 11, 2025 | seekingalpha.comTrump Beats Estimates And Raises GuidanceJuly 9, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFTRP, DMT, TLT, and KDA Company DescriptionsSmall Pharma CVE:DMTC$0.15 -0.01 (-6.25%) As of 10/20/2023Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.Field Trip Health NASDAQ:FTRPField Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.KDA Group CVE:KDAC$0.26 -0.01 (-1.89%) As of 02:19 PM EasternKDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services. The company also offers PREDICTIVE e-Prescriber software for assisting doctors; and KRx, a cloud-based solution that analyzes each user's prescription pattern and displays the appropriate expected medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. was founded in 2009 and is headquartered in Thetford Mines, Canada.iShares 20+ Year Treasury Bond ETF NASDAQ:TLT$89.74 +0.51 (+0.57%) Closing price 04:00 PM EasternExtended Trading$89.66 -0.08 (-0.09%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Despite Pullback, Rocket Lab Still Looks Primed for a Breakout Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Should You Buy Figma Stock After Its 55% Post-IPO Drop? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
